Brind.

The FDA reviewed the altered lignin alfalfa trait, which paves the way for S&W to offer commercial varieties in the United States.

1 report, 0 independent Updated Jun 24

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

FDA S&W

Keep exploring

The entities involved

FDA
- Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
- A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
S&W
professional services firm

Nothing else this week.

Coverage

Newest first; wire copies grouped

Jun 24Unknown outlet